Susquehanna International »

Bioxcel Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2026-06-30 $24k 17k 1.41

More positions owned by Susquehanna International

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)

View all positions for Susquehanna International

Top funds holding Bioxcel Therapeutics

Millennium Management
Oaktree Capital Management
Vanguard Capital Management
Oaktree Fund Advisors
Geode Capital Management
BlackRock
UBS Group
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
FMR
Wiley Bros.-aintree Capital
Jones Financial Companies, L.L
Northern Trust
HighTower Advisors

View all funds holding Bioxcel Therapeutics